David A. Siegel Enzo Biochem Inc Transaction History

Two Sigma Advisers, LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.9 - $3.47 $147,900 - $176,970	-51,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.17 - $4.09 $450,457 - $581,189	-142,100 Reduced 73.59%	51,000 $164,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $3.77 $477,385 - $597,922	158,600 Added 459.71%	193,100 $684,000
Q2 2021 Aug 16, 2021	BUY	$2.86 - $3.61 $98,670 - $124,545	34,500 New	34,500 $109,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.02 $127,260 - $190,260	-63,000 Closed	0 $0

Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.22 $42,308 - $64,261	-19,957 Reduced 24.06%	63,000 $141,000
Q1 2020 May 15, 2020	SELL	$1.82 - $3.87 $38,402 - $81,657	-21,100 Reduced 20.28%	82,957 $210,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $46,774 - $66,976	-18,200 Reduced 14.89%	104,057 $274,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $4.0 $109,262 - $145,200	36,300 Added 42.23%	122,257 $440,000
Q2 2019 Aug 14, 2019	SELL	$2.79 - $4.31 $18,972 - $29,307	-6,800 Reduced 7.33%	85,957 $290,000
Q1 2019 May 15, 2019	SELL	$2.54 - $4.02 $12,700 - $20,099	-5,000 Reduced 5.11%	92,757 $253,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $21,687 - $37,027	-8,816 Reduced 8.27%	97,757 $272,000
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $9,525 - $13,825	2,500 Added 2.4%	106,573 $439,000
Q2 2018 Aug 14, 2018	BUY	$5.06 - $6.78 $13,155 - $17,628	2,600 Added 2.56%	104,073 $540,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $337,287 - $436,611	-41,385 Reduced 28.97%	101,473 $827,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $1.49 Million - $1.63 Million	142,858	142,858 $1.5 Million

16.6M

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $53.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.